Independent Survey: SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies
Dear ESID Member,
We at ESID Board want to pay your immediate attention to an ongoing independent survey by the COVID Human Genetic Effort on the clinical characteristics of SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies.
We consider this an important and timely survey. If your center has such patients but you have not yet responded to the survey, and please consider, whether your center could participate in it.
Practical issues are explained in the attachment below by the researchers themselves.